Does Aetna Cover Weight Loss Treatment in New York? A 2026 Guide

Last updated: August 27, 2026

Aetna members in New York often ask whether a commercial plan may pay for online weight loss care, GLP-1 medications, or related visits. Coverage typically varies by employer group, individual marketplace plan, and formulary. This 2026 guide explains how federal mental health parity, New York insurance law, CVS/Caremark pharmacy rules, and telehealth rules may affect access. It does not replace your plan documents.

See if you may qualify for online weight loss care with licensed providers. Klarity Health works with 2,000+ clinicians. Coverage is not guaranteed. You should verify benefits before you book.

TLDR

• Aetna may cover medically necessary obesity evaluation and some anti-obesity medications in New York, depending on your plan and prior authorization.
• New York Insurance Law §§ 3221 and 4303 (Timothy’s Law) and MHPAEA apply to mental health and substance use disorder benefits. They do not, by themselves, require GLP-1 coverage for weight management.
• Aetna typically uses CVS/Caremark as PBM. Zepbound was removed from many Caremark formularies on July 1, 2025 and reinstated October 1, 2026. Wegovy, Saxenda, Contrave, phentermine, and orlistat still depend on your specific list.
• HHS and DEA telemedicine flexibilities for controlled substances currently run through December 31, 2026. Phentermine and Qsymia are Schedule IV; GLP-1s, Contrave, and orlistat are not scheduled.
• Verify benefits on your Aetna member ID card, then call the number on the card. For commercial plan disputes, New York DFS: (800) 342-3736.

If you are in crisis, call or text 988.

Does Aetna cover weight loss treatment in New York?

Often, Aetna commercial plans in New York may cover an evaluation for obesity or overweight when a clinician documents medical necessity. Medication coverage is a separate pharmacy decision. Some plans exclude anti-obesity drugs entirely. Others place GLP-1s on a high specialty tier with step therapy and BMI documentation.

New York’s Timothy’s Law and federal MHPAEA rules address mental health and SUD parity. Weight-loss medications for obesity are generally not treated as a mandated MH/SUD benefit. A depression or anxiety diagnosis does not automatically unlock Wegovy or Zepbound.

Related Aetna New York guides: ADHD, anxiety, and depression.

Browse conditions Klarity treats.

Mental health parity versus obesity benefits

New York Insurance Law §§ 3221 and 4303 (Timothy’s Law) require many insured plans to cover mental health care on par with medical/surgical benefits. Telehealth payment rules in §§ 3217-h and 4306-g typically require comparable coverage for virtual visits when the service is otherwise covered. Those statutes do not create a statewide mandate that every Aetna plan must cover GLP-1s for weight loss.

Self-funded ERISA employer plans follow federal rules and the employer’s SPD, not Timothy’s Law. Medicare Advantage and Medicaid products follow CMS and New York DOH rules. Always check which product you hold.

Telehealth weight loss visits

If your Aetna plan covers obesity medicine or nutrition counseling in person, New York telehealth rules often require comparable coverage for a video visit with an in-network clinician licensed in New York. Copays and deductibles still apply.

DEA-registered clinicians may prescribe certain controlled medications via telemedicine under the current HHS/DEA flexibility through December 31, 2026 (Federal Register extension; HHS announcement). Phentermine and phentermine/topiramate (Qsymia) are Schedule IV. Semaglutide, tirzepatide, liraglutide, naltrexone/bupropion (Contrave), and orlistat are not controlled substances, so Ryan Haight rules do not apply to those products.

CVS/Caremark, GLP-1s, and prior authorization

Aetna typically routes pharmacy benefits through CVS Caremark. Formulary placement and prior authorization sit with Caremark, not the medical claim for the visit.

Key 2025-2026 Caremark facts patients still mix up:

• Many commercial Caremark lists removed Zepbound (tirzepatide) on July 1, 2025.
• CVS Health later expanded GLP-1 access options, including removing a new-to-market block effective June 1, 2026 on some products (CVS Health, May 28, 2026).
• Zepbound reinstatement on many Caremark formularies is October 1, 2026. Until then, your list may prefer Wegovy or exclude anti-obesity GLP-1s.

PA packets often ask for BMI, comorbidity notes, prior lifestyle-program attempts, and a plan for ongoing monitoring. A visit on Klarity does not by itself approve the drug. Search your medication on Aetna’s Find a Medication tool and confirm with Caremark.

What a weight loss evaluation typically includes

A licensed clinician typically reviews medical history, medications, blood pressure, BMI, eating patterns, and contraindications (for example pregnancy, certain thyroid or GI conditions, or a history of pancreatitis). They may order labs, discuss nutrition and activity, and decide whether a medication is appropriate. They may also screen for depression or binge-eating symptoms that change the plan.

Klarity Health is a telehealth marketplace. Independent clinicians in the network provide care. They do not promise a specific drug.

Check if your plan may cover an online weight loss visit.

How to verify Aetna benefits in New York

1. Confirm the product on your ID card (PPO, HMO, EPO, Medicare Advantage, or Medicaid).
2. Ask whether obesity medicine, nutrition counseling, and anti-obesity drugs are covered benefits or exclusions.
3. Ask which PBM processes pharmacy claims (typically Caremark) and whether Wegovy, Zepbound, Saxenda, Contrave, phentermine, or orlistat appear on the 2026 list.
4. Ask about PA, step therapy, quantity limits, and preferred pharmacies.
5. Ask whether a New York–licensed telehealth clinician is in network for that CPT/E/M code.

Write down the reference number from the call.

Appeals and DFS complaints

If Aetna denies a visit or a medication, use the internal appeal in your denial letter. Commercial fully insured New York plans may then go to DFS. Call DFS at (800) 342-3736 or file through dfs.ny.gov. Medicaid, Essential Plan, and Child Health Plus complaints typically go to the New York Department of Health, not DFS. Self-funded ERISA plans follow the employer’s federal appeal path.

Disclaimer

Insurance coverage varies by plan, employer, and year. This article is educational and is not a benefits determination, diagnosis, or guarantee that Aetna will pay for any service or medication. Verify benefits before you book. If you have a medical emergency, call 911. For a mental health crisis, call or text 988.

Verify your benefits and see if you may qualify · Explore conditions